We are a global network of specialists working together to conquer lung and thoracic cancers worldwide.

May Webinar: IASLC Lung Cancer Grand Rounds Series - Lung Cancer Screening - What should you know.

Global Curricular Framework for Thoracic Cancer Now Available

Chicago Multidisciplinary Symposium in Thoracic Oncology. Abstract submission deadline May 7, 2014.

Researchers

ALK IHC Shown to Be Sensitive and Accurate in NSCLC

Findings Support Algorithmic Use of Test in Evaluation of NSCLC

DENVER – A new study shows that immunohistochemical (IHC) analysis is sensitive, specific, and accurate for detecting ALK protein expression based on gene rearrangement in non-small cell lung cancer (NSCLC).

Study Clarifies Molecular Mechanisms of RET Rearrangement

RET Fusion Occurs through Multiple Pathways

DENVER – Investigators have identified the molecular mechanisms underlying RET rearrangement, a genetic alteration recognized as a driver mutation in a small subset of lung adenocarcinoma.

ELCC 2014: Late and Chronic Toxicities of New Targeted Therapies

Video

Dr. Tony Mok, President of IASLC, offers an overview on most common toxicities related to targeted therapies in NSCLC.

Practitioners

ALK IHC Shown to Be Sensitive and Accurate in NSCLC

Findings Support Algorithmic Use of Test in Evaluation of NSCLC

DENVER – A new study shows that immunohistochemical (IHC) analysis is sensitive, specific, and accurate for detecting ALK protein expression based on gene rearrangement in non-small cell lung cancer (NSCLC).

Study Clarifies Molecular Mechanisms of RET Rearrangement

RET Fusion Occurs through Multiple Pathways

DENVER – Investigators have identified the molecular mechanisms underlying RET rearrangement, a genetic alteration recognized as a driver mutation in a small subset of lung adenocarcinoma.

ELCC 2014: Late and Chronic Toxicities of New Targeted Therapies

Video

Dr. Tony Mok, President of IASLC, offers an overview on most common toxicities related to targeted therapies in NSCLC.

Patients

ALK IHC Shown to Be Sensitive and Accurate in NSCLC

Findings Support Algorithmic Use of Test in Evaluation of NSCLC

DENVER – A new study shows that immunohistochemical (IHC) analysis is sensitive, specific, and accurate for detecting ALK protein expression based on gene rearrangement in non-small cell lung cancer (NSCLC).

Study Clarifies Molecular Mechanisms of RET Rearrangement

RET Fusion Occurs through Multiple Pathways

DENVER – Investigators have identified the molecular mechanisms underlying RET rearrangement, a genetic alteration recognized as a driver mutation in a small subset of lung adenocarcinoma.

ELCC 2014: Late and Chronic Toxicities of New Targeted Therapies

Video

Dr. Tony Mok, President of IASLC, offers an overview on most common toxicities related to targeted therapies in NSCLC.